NIH R01 · 2024
Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity2 (CISTEM2)
Summary/Abstract Kidney transplant (KT) survival faces challenges from increased patient complexity, use of non-standard donors, and longer cold ischemic times. Despite refinement in immunosuppression (IS) management over several decades, nearly all KT patients experience progressive loss of allograft function, leading to eventual graft failure while still risking life-threatening IS-related complications. Development of evidence-based IS management practice to optimize long-term KT function has been limited by the need for detailed, longitudinal clinical data for large representative populations. Our previous NIDDK-supported R01 grant (Choosing IS regimens in kidney Transplant by Efficacy…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.